摘要
易损斑块的形成是急性冠脉综合征(ACS)发生的病理学基础。早期识别和诊断,对急性心脑血管事件的一级预防、个体化治疗及二级预防均有重要意义。
出处
《岭南心血管病杂志》
2014年第1期125-127,共3页
South China Journal of Cardiovascular Diseases
参考文献26
-
1CONTI C R. Updated pathophysiologic eoncepts in unstable eoronary artery disease[J]. Am Heart J, 2001, 141 (2 Suppl ) : S12-S14.
-
2NAGHAVI M, LIBBY P, FALK E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I [J]. Circulation, 2003, 108( 14): 1664 - 1672.
-
3VIRMANI R, KOLODGIE F D, BURKE A P, et al. Lessons from sudden coronary death: comprehensive morphological classification scheme for atherosclerotic lesions [ J ]. Arterioscler Thromb Vasc Biol, 2000, 20(5): 1262-1275.
-
4陈学军.C反应蛋白与动脉粥样硬化[J].中国动脉硬化杂志,2002,10(4):355-357. 被引量:42
-
5WILLERSON J T, RIDKER P M. Inflammation as a cardiova- scular risk factor[J]. Circulation, 2004, 109(21 suppl 1): Ⅱ2-Ⅲ10.
-
6谭虹,余丹青,张莹,周颖玲.急性冠脉综合征临界病变易损斑块变化与超敏C反应蛋白的关系[J].实用医学杂志,2010,26(12):2148-2150. 被引量:10
-
7KATO M, DOTE K, NAGANUMA T, et al. Clinical predictors of culprit plaque rupture assessed on intravascular ultrasound in acute coronary syndrome [J]. Circ J, 2010, 74 (9) : 1936- 1942.
-
8MOMIYAMA Y, OHMORI R, TANAKA N, et al. High ptasma levels of matrix metalloproteinase-8 in patients with unstable angina [J]. Atherosclerosis, 2010, 209 (1) : 206- 210.
-
9UEMURA S, MATSUSHITA H, LI W, et al. diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress[J]. Circ Res, 2001, 88(12): 1291-1298.
-
10RODRIGUEZ J A, ORBE J, MARTINEZ DE LIZARRONDO S, et al. Metalloproteinases and atherothrombosis: MMP-IO mediates vascular remodeling promoted by inflammatory stimuli [J]. Front Biosci, 2008, 13: 2916-2921.
二级参考文献117
-
1孙璐,韦立新,石怀银,郭爱桃,侯宁,游联璧.冠状动脉粥样硬化斑块内血管新生与斑块稳定的关系[J].中华病理学杂志,2003,32(5):427-431. 被引量:42
-
2赵全明,许金鹏,王蒨,陈大明,米洪志.^(99)Tc^m标记的annexinV检测不稳定动脉粥样硬化斑块的实验研究[J].中国医学影像技术,2005,21(9):1349-1352. 被引量:5
-
3徐浩,陈可冀.冠心病易损斑块与中西医结合干预的实践与思考[J].中西医结合心脑血管病杂志,2006,4(11):941-942. 被引量:3
-
4张京春,陈可冀,郑广娟,张文高,史大卓,殷惠军,刘龙涛.解毒活血中药配伍对载脂蛋白E基因敲除小鼠主动脉NF-κB与MMP-9表达的调控作用[J].中国中西医结合杂志,2007,27(1):40-44. 被引量:34
-
5WULFF H, CALABRESI P A, ALLIE R, et al. The voltage-gated Kvl. 3 K(+) channel in effector memory T cells as new target for MS[J]. J Clin Invest, 2003, 111: 1703-1713.
-
6BAIDYA S G, ZENG Q T. HELPER T ceils and atherosclerosis: the cytokine web[J]. Postgrad Med J, 2005, 81: 746-752.
-
7GUPTA S, PABLO A M, JIANG X, et al. IFN- gamma potentiates atherosclerosis in ApoE knock-out mice[J]. J Clin Invest, 1997, 99: 2752-2761.
-
8KOGA M, KAI H, YASUKAWA H, et al. Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in ApoE-knockout mice[J]. Circ Res, 2007, 101: 348-356.
-
9CHOY J C, HUNG V H, HUNTER A L, et al. Granzyme B induces smooth muscle cell apoptosis in the absence of perforin: involvement of extracellular matrix degradation[J]. Arterioscler Thromb Vasc Biol, 2004, 24: 2245-2250.
-
10CHAMBERLAIN C M, GRANVILLE D J. The role of Granzyme B in atheromatous diseases. Can J Physiol Pharmaeol, 2007, 85: 89--95.
共引文献110
-
1陈欣,易光辉,涂玉林.妊娠相关血浆蛋白A与动脉粥样硬化的关系研究进展[J].中国动脉硬化杂志,2004,12(6):743-744. 被引量:1
-
2范秀珍 ,胡维诚 .清热解毒类中药抗动脉粥样硬化作用机制的研究进展[J].中国动脉硬化杂志,2004,12(2):246-248. 被引量:26
-
3杨永宗.中国动脉粥样硬化病理生理学研究近况[J].中国动脉硬化杂志,2004,12(4):481-489. 被引量:33
-
4马亚兵,高海青,伊永亮,冯孟林,靖百谦,于洋.葡萄籽原花青素降低动脉粥样硬化兔血清C反应蛋白水平[J].中国动脉硬化杂志,2004,12(5):549-552. 被引量:11
-
5吕军,肖敏,刘久波,毛达勇,宋培仙.血管内皮生长因子_(165)和白细胞介素-8促兔动脉粥样硬化斑块形成作用的探讨[J].微循环学杂志,2005,15(1):34-36. 被引量:2
-
6蒋娜,匡希斌.CD40-CD40L与急性冠脉综合征[J].美国中华临床医学杂志,2005,7(1):77-79.
-
7袁惠敏,沈丽,杨卫红,潘志红,张江蓉,王一尘.老年高血压患者颈动脉病变与C反应蛋白的相关研究[J].中国医师杂志,2005,7(6):774-776. 被引量:2
-
8陈学军,LI,Jian-jun.C反应蛋白激活单核细胞核因子-кB及辛伐他汀干预[J].实用医学杂志,2005,21(15):1615-1617. 被引量:6
-
9何贵新,莫云秋,何劲松.急性心肌梗死介入治疗前后C-反应蛋白的变化[J].广西医学,2005,27(10):1569-1570.
-
10崔燕,金润华,谢春毅,黄海云,劳晓翔.普伐他汀早期应用对急性冠状动脉综合征血管炎症反应及内皮功能的影响[J].中国动脉硬化杂志,2005,13(3):348-350. 被引量:2
同被引文献41
-
1柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2117
-
2TARGHER G,DAY C P,BONORA E.Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease[J].N Engl J Med,2010,363:1341-1350.
-
3SDERBERG C,STL P,ASKLING J,et al.Decreased survival of subjects with elevated liver function tests during a 28-year follow-up[J].Hepatology,2010,51:595-602.
-
4KRAWCZYK M,BONFRATE L,PORTINCASA P.Nonalcoholic fatty liver disease[J].Best Pract Res Clin Gastroenterol,2010,24:695-708.
-
5ONI E T,AGATSTON A S,BLAHA M J,et al.A systematic review:burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver;should we care?[J].Atherosclerosis,2013,230:258-267.
-
6CHIANG C H,HUANG C C,CHAN W L,et al.The severity of non-alcoholic fatty liver disease orrelates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population[J].Clin Biochem,2010,43:1399-1404.
-
7Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med, 2013, 368 ( 21 ) : 2004-2013.
-
8Libby P, Ridker P M, Maseri A. Inflammation and atherosclerosis. Circulation ,2002, 105 ( 9 ) : 1135-1143.
-
9Hansson G K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med,2005,352(16) :1685-1695.
-
10Chen S, Crother T R, Arditi M. Emerging role of IL-17 in atherosclerosis. J Innate Immun, 2010,2(4) :325-333.
引证文献4
-
1刘永生,韩洪波,赵佳辉.β_3肾上腺素能受体基因多态性与冠心病发病相关性的研究[J].中国实验诊断学,2015,19(7):1157-1159. 被引量:3
-
2章秋芳,王中英,徐建平.非酒精性脂肪性肝病与冠状动脉粥样硬化相关性及冠脉病变特点分析[J].中国中西医结合消化杂志,2016,24(2):112-115. 被引量:5
-
3赖永坤,吕伟标,李锦荣.血清S100B,MCP-1,COX-2及hs-CRP与急性冠脉综合征的相关性分析[J].标记免疫分析与临床,2016,23(6):672-675. 被引量:16
-
4王毅,庄建芬,刘君,林刚.依折麦布联合阿托伐他汀对急性冠脉综合征患者临床疗效及血清MCP-1、CCL19、脂蛋白磷脂酶A2水平的影响[J].贵州医药,2017,41(9):960-961. 被引量:6
二级引证文献30
-
1Xin-Dong Liu,Xin Wang,Li-Juan Zhang,Le Yang,Yi Zhou.Effect of butylphthalide injection on inflammatory factors, neurological factors and hemorheology in patients with acute cerebral infarction[J].Journal of Hainan Medical University,2018,24(4):35-38.
-
2梅歆.2型糖尿病合并非酒精性脂肪肝与颈动脉粥样硬化关系的研究[J].中国医学创新,2016,13(26):112-115. 被引量:3
-
3张鹏飞,全丰芝,杨艳.根除幽门螺杆菌对非酒精性脂肪性肝病的影响[J].中国康复理论与实践,2017,23(6):725-727. 被引量:4
-
4王毅,庄建芬,刘君,林刚.依折麦布联合阿托伐他汀对急性冠脉综合征患者临床疗效及血清MCP-1、CCL19、脂蛋白磷脂酶A2水平的影响[J].贵州医药,2017,41(9):960-961. 被引量:6
-
5任健.血清FGF21和hs-CRP水平与急性冠脉综合症的相关性分析[J].医学检验与临床,2017,28(5):15-18. 被引量:1
-
6刘信东,王欣,张利娟,杨乐,周怡.丁苯酞注射液对急性脑梗死患者炎症因子、神经因子及血液流变学的影响[J].海南医学院学报,2018,24(4):464-467. 被引量:23
-
7周丹,张芃,张照英,安艳红.维持性血液透析尿毒症患者外周血MCP-1、TNF-α、IL-6和hs-CRP水平对血管通路功能的影响[J].临床误诊误治,2018,31(2):91-94. 被引量:28
-
8曾宏亮,曾祥俊.阿替普酶联合丁苯酞注射液治疗急性脑梗死的效果[J].中国当代医药,2018,25(23):148-150. 被引量:4
-
9杨文典,孟志剑,丁亚楠.依折麦布联合阿托伐他汀对LDL-C未达标急性冠状动脉综合征患者易损斑块的影响[J].中国实用医刊,2018,45(16):110-112. 被引量:5
-
10范杰.大株红景天注射液对急性冠脉综合征患者炎症因子及心功能的影响[J].锦州医科大学学报,2018,39(5):31-34. 被引量:2
-
1许建明.肠易激综合征药物治疗的临床评价与研究进展[J].临床消化病杂志,2016,28(6):380-382. 被引量:5
-
2李小明,高鑫.非酒精性脂肪性肝病与动脉粥样硬化之间关系的研究进展[J].中华内分泌代谢杂志,2011,27(9):784-786. 被引量:4
-
3周妙,朱永宏.炎性反应与主动脉夹层及其腔内隔绝术的相关性[J].岭南心血管病杂志,2014,20(6):806-808. 被引量:2
-
4肖华,向定成.急性B型主动脉夹层腔内修复治疗时机[J].岭南心血管病杂志,2014,20(6):801-802. 被引量:3
-
5梁旭东,肖本楼.中国炭疽流行及研究现状(提要)(英文)[J].地方病通报,1997,12(4):82-85.
-
6丁殿勋,武英,吴旭辉.美国心脏病学会和美国心脏协会关于急性心肌梗塞病人治疗指南(实施提要)[J].海军总医院学报,1998,11(1):59-64.
-
7邵瑛.经桡动脉行经皮冠状动脉介入治疗后穿刺部位的护理进展[J].岭南心血管病杂志,2013,19(4):527-528. 被引量:9
-
8汪秦,沈树斌,郝述善.答对《冠状动脉狭窄对左室射血机能的影响》一文的质疑[J].中国循环杂志,1990,5(6):504-505.
-
9本刊编辑部.关于中英文摘要书写格式要求[J].组织工程与重建外科杂志,2011,7(4):240-240.
-
10张蓓蕾.埃博拉出血热提要[J].中国乡村医药,2001,8(9):50-51.